T-cell therapy

sarcoma

FDA signs off on first engineered cell therapy for a solid tumor

Adaptimmune has won FDA approval for its synovial sarcoma treatment Tecelra, the first engineered cell therapy for a solid tumor.

Kevin Dunleavy Aug 2, 2024 8:56am

Amtagvi

FDA approves first T-cell therapy for a solid tumor

Feb 17, 2024 12:15pm

FDA

FDA sets date for high-profile CAR-T advisory committee meeting

Feb 2, 2024 1:31pm

FDA

FDA tweaks demand for boxed warning on Gilead's CAR-T label

Jan 24, 2024 10:29am

FDA Building

FDA wants classwide boxed warning on existing CAR-Ts

Jan 23, 2024 3:27am

topic report

bottleneck

CAR-T hype faces infrastructure reality check

Jan 15, 2024 3:00am